APOE and Parkinson disease: Since PD-MCI generally occurs later in PD, with about 25% of PD patients experiencing it at the time of diagnosis and about 40–50% after a 5 year follow up [2], it is possible that APOE4’s influence on GMV and CTh may have not manifested yet in our study.